info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Acute Respiratory Infection Market By Infection Type (Upper Respiratory Tract Infections, Lower Respiratory Tract Infections); By Pathogen Type (Viral, Bacterial, Others); By Treatment Type (Antibiotics, Antivirals, Immunomodulators, Supportive Care); By End User (Hospitals, Clinics, Ambulatory Care Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Respiratory Infection Market is expected to reach a valuation of approximately USD 69.1 billion in 2024 and grow steadily to hit USD 94.6 billion by 2030 , expanding... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Aicardi Goutieres Syndrome Market By Treatment Type (Symptomatic Therapy, Experimental/Investigational Therapies); By Route of Administration (Oral, Parenteral, Emerging Routes); By End User (Specialty Hospitals, Academic & Research Institutes, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aicardi Goutieres Syndrome (AGS) Market will witness a steady CAGR of 7.8% , valued at USD 92 million in 2024 , and is projected to reach... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Chronic Venous Insufficiency Treatment Market By Treatment Type (Compression Therapy, Pharmacological Therapy, Endovenous Ablation, Sclerotherapy, Surgical Vein Stripping); By Disease Severity (Early-Stage CVI, Moderate CVI, Severe CVI); By End User (Hospitals, Specialized Vascular Clinics, Ambulatory Surgical Centers, Diagnostic & Primary Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Venous Insufficiency Treatment Market will grow at a CAGR of 6.5% , valued at USD 3.9 billion in 2024 , and expected to reach USD 6.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Thromboembolic Pulmonary Hypertension Market By Treatment Modality (Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, Pharmacotherapy); By Drug Class (Soluble Guanylate Cyclase Stimulators, Prostacyclin Analogs, Endothelin Receptor Antagonists, Anticoagulants); By End User (Specialized CTEPH Centers, Tertiary Hospitals, General Hospitals, Diagnostic & Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Market will witness a robust CAGR of 6.8% , valued at USD 1.7 billion in 2024 , exp... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Cocaine Intoxication Treatment Market By Product Type (Benzodiazepines, Cardiovascular Stabilizers, Antipsychotics, Emerging Pharmacotherapies); By Route of Administration (Oral, Intravenous, Intramuscular, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cocaine Intoxication Treatment Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 6.5% . The market is valued at USD 1.8 billion in 2024 a... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Complement 3 Glomerulopathy Treatment Market By Drug Class (Complement Inhibitors, Immunosuppressants, Corticosteroids, Others); By Route of Administration (Intravenous, Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement 3 Glomerulopathy Treatment Market will witness a robust CAGR of 10.2%, valued at USD 615.0 million in 2024 , expected to reach... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cold Agglutinin Disease Treatment Market By Drug Class (Monoclonal Antibodies, Immunosuppressants, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Agglutinin Disease ( CAD ) Treatment Market will witness a steady CAGR of 8.1%, valued at USD 620.0 million... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Vernal Keratoconjunctivitis Market By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Biologics); By Route of Administration (Eye Drops, Gels, Ocular Inserts); By Patient Age Group (Pediatric, Adolescent, Adult-Onset); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vernal Keratoconjunctivitis Market is projected to grow at a CAGR of 6.8% , valued at USD 332.0 million in 2024 , and ex... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Rare NRG1 Fusion Market By Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, RNA Therapies & Antibody-Drug Conjugates); By Cancer Type (Non-Small Cell Lung Cancer, Pancreatic Cancer, Others); By Diagnostic Method (CGP via NGS, FISH & RT-PCR); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rare NRG1 Fusion Market is projected to grow at a CAGR of 37.8% , with an estimated valuation of $ 187.0 million... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Non-Cystic Fibrosis Bronchiectasis Market By Treatment Type (Inhaled Antibiotics, Oral Antibiotics, Bronchodilators, Anti-inflammatory Therapies); By Diagnostic Modality (High-Resolution CT, Pulmonary Function Testing, Microbiological Testing); By End User (Hospitals, Pulmonology Clinics, Specialty Pharmacies, Homecare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Cystic Fibrosis Bronchiectasis Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated USD 2.1 billion by 2030 , up from around USD 1.4 bi... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Neoantigen Cancer Vaccine Market By Technology Platform (mRNA-based, Peptide-based, DNA-based, Dendritic Cell-based); By Cancer Type (Melanoma, NSCLC, Colorectal, Pancreatic, Glioblastoma, Others); By Delivery Mechanism (Lipid Nanoparticle, Intradermal Injection, Electroporation); By End User (Academic Cancer Centers, Specialty Oncology Hospitals, CROs, Immunotherapy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Cancer Vaccine Market is projected to grow at a robust CAGR of 24.7% from 2024 to 2030, starting at an estimated USD 1.2 billion in 2024 and re... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

mRNA Therapeutics Market By Product Type (mRNA Vaccines, mRNA Therapeutics); By Application (Infectious Diseases, Oncology, Genetic Disorders, Autoimmune Diseases, Cardiovascular and Others); By Route of Administration (Intramuscular, Intravenous, Inhalation/Intranasal); By End User (Hospitals & Academic Centers, Public Health Agencies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Therapeutics Market is projected to expand at a strong pace, valued at approximately USD 45.2 billion in 2024 and expected to reach around USD 98.7 billion by... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Intratumoral Cancer Therapies Market By Therapy Type (Oncolytic Viruses, Cytokine-Based Therapies, Gene Therapies, Small Molecule Injectables); By Cancer Type (Melanoma, Head and Neck, Breast, Lung, Pancreatic, Brain Tumors); By Route of Administration (Image-Guided Injection, Intraoperative Delivery, Endoscopic Injection); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Intratumoral Cancer Therapies Market is expected to grow at a robust CAGR of 10.6% , valued at an estimated USD 1.3 billion in 2024 , and... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Interstitial Lung Disease Market By Disease Type (IPF, CTD-ILD, HP, Occupational/Environmental, Sarcoidosis, Drug-Induced, Others); By Drug Class (Antifibrotics, Corticosteroids, Immunosuppressants, Biologics, Novel Agents); By Route of Administration (Oral, Inhalation, Injectable); By Diagnostic Tool (HRCT, PFTs, Biomarkers, Genetic Testing, Lung Biopsy); By End User (Tertiary Hospitals, Specialist Clinics, Imaging Centers, Community Hospitals, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Interstitial Lung Disease Market is expected to grow at a steady CAGR of around 6.1% , valued at USD 4.7 billion in 2024 and projected to reach nearly USD 6.7 bill... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

IgA Nephropathy Market By Therapy Type (Corticosteroid-Sparing Therapies, Endothelin Receptor Antagonists, Complement Inhibitors, Supportive Care); By Route of Administration (Oral, Injectable); By End User (Academic and Tertiary Hospitals, Specialty Nephrology Clinics, Retail and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global IgA Nephropathy Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated market size of USD 5.8 billion by 2030 , up ... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

HER2 Positive Gastric Cancer Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Tyrosine Kinase Inhibitors, Immunotherapies); By Line of Treatment (First-Line, Second-Line, Third-Line & Beyond); By Diagnostic Modality (IHC, FISH, NGS); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global HER2 Positive Gastric Cancer Market will witness a steady CAGR of 6.8% , valued at USD 3.7 billion in 2024 , and projected to reach nearl... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Hematopoietic Stem Cells Transplantation Market By Transplant Type (Autologous, Allogeneic); By Source of Stem Cells (Bone Marrow, Peripheral Blood, Umbilical Cord Blood); By Application (Oncology, Hematology, Rare Genetic Disorders); By End User (Academic Hospitals, General Hospitals, Specialty Transplant Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hematopoietic Stem Cells Transplantation ( HSCT ) Market will expand at a robust CAGR of 8.1% , valued at USD 6.7 billion in 2024 and pro... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Fibromyalgia Treatment Market By Drug Class (SNRIs, Anticonvulsants, Tricyclic Antidepressants, Muscle Relaxants, Others); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibromyalgia Treatment Market is projected to grow at a compound annual growth rate of 5.2 % , reaching an estimated value of USD... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

DiGeorge Syndrome Drug Market By Drug Class (Immunomodulators and Immunoglobulins, Hormone Replacement Therapies, Antipsychotics and Behavioral Medications, Supportive Medications); By Therapeutic Target (Immune System Dysfunction, Endocrine and Metabolic Dysfunction, Neurodevelopmental and Psychiatric Symptoms, Congenital Heart Defects and Surgical Support); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies and Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digeorge Syndrome Drug Market is projected to grow at a CAGR of 8.1% from 2024 to 2030 , moving from an estimated USD 328Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Cutaneous Lupus Erythematosus Market By Disease Subtype (Acute CLE, Subacute CLE, Chronic CLE); By Treatment Class (Topical Agents, Antimalarials, Immunosuppressants, Biologics & Small Molecules); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cutaneous Lupus Erythematosus (CLE) Market is projected to expand at a CAGR of 6.4% , reaching USD 3.1 billion by 2030 , up from USD 2.1 billion i... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Chronic Spontaneous Urticaria Treatment Market By Treatment Type (Antihistamines, Biologics, Leukotriene Receptor Antagonists, Corticosteroids, Others); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Spontaneous Urticaria (CSU) Treatment Market is projected to expand steadily between 2024 and 2030, driven by a combination of rising disease prev... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Chronic Rhinosinusitis With Nasal Polyps Market By Treatment Type (Corticosteroids, Biologics, Surgery, Others); By Route of Administration (Intranasal, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Rhinosinusitis With Nasal Polyps Market will witness a steady CAGR of 6.8% , valued at USD 5.1 billion in 2024 , expected to reac... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market By Drug Class (Bronchodilators, Corticosteroids, PDE-4 Inhibitors, Combination Therapies, Others); By Route of Administration (Inhalation, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is projected to grow at a steady CAGR of 6.1% , with an estimated value of USD 20.1 ... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Chronic Lymphocytic Leukemia Market By Therapy Type (Chemo-Immunotherapy, BTK Inhibitors, BCL2 Inhibitors, Others); By Diagnostics (MRD Assays, Cytogenetic Testing, Flow Cytometry, Others); By End User (Hospitals, Specialist Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Lymphocytic Leukemia Market will witness a steady CAGR of 6.1 % ,valued at around 10.6 billion US dollars in 2024Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Inducible Urticaria Treatment Market By Drug Class (Antihistamines, Leukotriene Receptor Antagonists, Biologics, Immunosuppressants); By Route of Administration (Oral, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Inducible Urticaria Treatment Market is estimated to be valued at around $1.3 billion in 2024 and is projected to reach roughly $2.1 billion by 2030 , rising at a ... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Chondrosarcoma Market By Type (Conventional, Dedifferentiated, Mesenchymal, Clear Cell); By Treatment Modality (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy); By End User (Academic Hospitals, Orthopedic Oncology Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondrosarcoma Market is poised for steady growth between 2024 and 2030, driven by expanding research pipelines, better diagnostics, and heightened awareness across rare bone tumors . While exact numbers f... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Chemotherapy-Induced Diarrhea Treatment Market By Treatment Type (Anti-Diarrheal Agents, Oral Rehydration Solutions, Probiotics, Biologics); By Chemotherapy Regimen (Fluoropyrimidines, Irinotecan, Combination Therapies, Others); By End User (Hospitals & Oncology Centers, Outpatient Clinics & Homecare, Pharmacies & Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chemotherapy-Induced Diarrhea Treatment Market is projected to witness a robust CAGR of 6.8%, valued at USD 1.2 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chemotherapy Induced Peripheral Neuropathy Treatment Market By Drug Class (Antidepressants, Anticonvulsants, Topical Agents, Opioids, Neuroprotective Agents); By Mechanism of Action (Pain Modulation, Neuroprotection, Nerve Regeneration); By Route of Administration (Oral, Injectable, Transdermal); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Chemotherapy Induced Peripheral Neuropathy ( CIPN ) Treatment Market is projected to grow at a CAGR of 7.3 %, reaching a... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

CD38 Monoclonal Antibody Drugs Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Multiple Myeloma, Chronic Lymphocytic Leukemia, Autoimmune Disorders, Other Hematologic Malignancies); By Distribution Channel (Hospital Pharmacies, Community Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD38 Monoclonal Antibody Drugs Market is projected to expand steadily between 2024 and 2030 , with an estimated value of USD 8.1 billion in 2024 and likel... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Catheter Related Bloodstream Infection Market By Product Type (Antimicrobial Catheters, CHG Dressings, Needleless Connectors, Catheter Lock Solutions); By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Fungal Pathogens); By End User (Hospitals, Dialysis Clinics, Infusion Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Catheter-Related Bloodstream Infection (CRBSI) Market is projected to grow steadily at a CAGR of 6.5% , reaching nearly USD 2.35 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Cardiac Amyloidosis Market By Product Type (Transthyretin Stabilizers, RNA Interference Therapies, Antisense Oligonucleotides, Monoclonal Antibodies, Diagnostics); By Application (Transthyretin Amyloidosis [Hereditary, Wild-type], Light Chain Amyloidosis); By End User (Hospitals, Specialty Cardiac Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Amyloidosis Market will grow at a CAGR of 10.8% , valued at USD 4.2 billion in 2024 , and projected to reach USD 7.8 billion by 2030 , according t... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Cancer Anorexia Market By Product Type (Appetite Stimulants, Corticosteroids, Progestogens, Cannabinoids, Nutraceuticals, Biologics/Peptides); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Anorexia Market is expected to grow at a CAGR of 6.8% , valued at USD 2.9 billion in 2024 , and projected to reach USD 4.3 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Bullous Keratopathy Market By Treatment Type (Corneal Transplantation [DMEK, DSAEK, Penetrating Keratoplasty], Pharmacological Therapy, Artificial Corneas, Supportive & Symptomatic Treatment); By Cause (Post-Cataract Surgery, Fuchs’ Dystrophy, Trauma, Infection, Congenital Disorders); By End User (Specialty Eye Hospitals, General Hospitals, ASCs, Academic/Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Keratopathy Market is projected to grow steadily from USD 1.12 billion in 2024 to reach around USD 1.61 billion by 2030 , reflecting a CAG... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Bronchopulmonary Dysplasia Treatment Market By Treatment Type (Corticosteroids, Surfactants, Diuretics, Bronchodilators, Pulmonary Vasodilators); By Route of Administration (Intravenous, Inhalation, Oral, Intratracheal); By End User (NICUs, Pediatric Hospitals, Outpatient Pediatric Clinics, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchopulmonary Dysplasia (BPD) Treatment Market is projected to expand steadily between 2024 and 2030, supported by rising preterm birth rates and advances in neonatal intensive care. Ba... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

BRCA Mutations Treatment Market By Treatment Type (PARP Inhibitors, Hormonal Therapy, Chemotherapy, Targeted Combinations); By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic and Others); By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BRCA Mutations Treatment Market is projected to reach a value of $5.8 billion in 2024 , with expectations to surpass $10.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Bone Metastasis Market By Treatment Type (Pharmaceuticals [Bisphosphonates, RANKL Inhibitors, Radiopharmaceuticals], Radiation Therapy, Surgical Interventions, Supportive Care); By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer, Thyroid & Others); By End User (Hospitals & Cancer Centers, Community Oncology Clinics, Specialty Orthopedic Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Metastasis Market is projected to expand steadily, reaching approximately USD 18.7 billion in 2024 and anticipated to surpass USD 27.9 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Blepharitis Market By Type (Anterior Blepharitis, Posterior Blepharitis, Mixed); By Treatment (Lid Hygiene Products, Prescription Pharmaceuticals, In-Office Procedures, Device-Based Home Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blepharitis Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 5.8% , reaching approximately USD 1.9 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Biliary Atresia Market By Treatment Type (Surgical Interventions, Liver Transplantation, Pharmacological Therapies); By Diagnosis Stage (Early Diagnosis, Delayed Diagnosis); By End User (Tertiary Pediatric Hospitals, Specialty Liver Transplant Units, General Hospitals with Pediatric Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biliary Atresia Market is projected to expand steadily between 2024 and 2030, driven by rising awareness of neonatal liver disorders, earlier diagnostic interventions, and ongoing advances... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Beta Thalassemia Market By Therapy Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy & Gene Editing, Bone Marrow/Stem Cell Transplantation); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Hematology Centers, Specialty Clinics, Retail & Online Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Beta Thalassemia Market is projected to expand steadily between 2024 and 2030, with an estimated valuation of USD 1.9 billion in 2024 and expected to reach USD 3.1... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Benign Prostatic Hyperplasia Treatment Market By Therapy Type (Pharmacological, Minimally Invasive Surgical Therapies, Surgical Procedures); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Urology Clinics); By End User (Hospitals & Teaching Institutions, Specialty Urology Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benign Prostatic Hyperplasia Treatment Market is projected to expand at a 6.9% CAGR, valued at $10.8 billion in 2024 and on track to reac... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

AXL Receptor Tyrosine Kinase Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Monoclonal Antibodies, Antibody-Drug Conjugates); By Application (Oncology, Fibrosis, Inflammatory Diseases); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global AXL Receptor Tyrosine Kinase (RTK) Inhibitors Market is anticipated to grow steadily between 2024 and 2030, with analysts estimating a ma... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Axial Spondyloarthritis Market By Drug Type (Biologics, csDMARDs, tsDMARDs); By Disease Type (Radiographic AxSpA, Non-Radiographic AxSpA); By End User (Hospitals, Specialty Rheumatology Clinics, Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Axial Spondyloarthritis (Axspa) Market is projected to witness a robust CAGR of 7.4 Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Trodelvy Market By Indication (Triple-Negative Breast Cancer, HR+/HER2- Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Others); By Line of Therapy (Second-Line, Third-Line and Beyond, Maintenance); By Distribution Channel (Hospital Pharmacies, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trodelvy Market will experience a strong growth trajectory between 2024 and 2030, rising from an estimated USD 1.62 billion in 2024 to nearly USD ... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

PIM Kinase Targeted Therapies Market By Drug Type (Selective PIM Kinase Inhibitors, Dual/Multi-Target Kinase Inhibitors); By Cancer Type (Hematologic Malignancies, Solid Tumors); By Line of Therapy (First-Line, Second-Line and Beyond); By Route of Administration (Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PIM Kinase Targeted Therapies Market is projected to witness strong expansion between 2024 and 2030, with an inferred CAGR of 10.1%. The market is valued at approximately ... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Lupus Nephritis Treatment Market By Drug Class (Immunosuppressants, Biologics, Corticosteroids, ACE Inhibitors & ARBs, Antimalarials); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lupus Nephritis Treatment Market is projected to grow at a CAGR of 10.4%, expanding from USD 1.6 billion in 2024 to approximately USD 2.9 billion ... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

CD40 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Fusion Proteins, Small Molecules); By Indication (Oncology, Autoimmune Diseases, Transplantation); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD40 Targeted Therapies Market is projected to grow at a robust CAGR of 11.8%, reaching an estimated valuation of USD 3.9 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market By Target Protein (Amyloid-β, Tau, α-Synuclein, Huntingtin, TDP-43, Others); By Therapeutic Modality (Monoclonal Antibodies, RNA/Antisense Therapies, Small Molecule Modulators, Gene Therapy & Advanced Platforms); By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s, Rare Proteinopathies); By Line of Therapy; By Region, Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The global Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market is projected to reach USD 1.7 billion by 2035, up from around USD 0.6 billion in 2025, growing at... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, NSCLC); By Line of Therapy (First-Line, Second-Line, Maintenance/Combo Therapy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PLK Targeted Therapies Market is gaining traction in oncology drug development, with an CAGR of around 8.5% from 2024 to 2030, valued at USD 1.1 b... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market is projected to grow at a CAGR of 32.6%, starting at an estimated USD 318 million in 202... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a CAGR of 8.9%, valued at USD 1.5 billion in 2024, and expected to reach USD 2.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market is projected to expand steadily between 2024 and 2030, registering a CAGR of 10.4%, valued at around USD 1.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is estimated at USD 675 million in 2024 and is projected to reach USD 1.02 billion by 2030, growing at a CAG... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is on a sharp upward trajectory — currently valued at USD 472.5 million in 2024, and expected to climb to USD... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

CD123 Targeted Therapy Market By Therapy Type (Antibody-Drug Conjugates, Monoclonal Antibodies, Bispecific Antibodies, CAR-T Therapies); By Application (Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Others); By End User (Academic & Research Hospitals, Cancer Specialty Centers, Community Hospitals & Clinics, CROs & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD123 Targeted Therapy Market is expected to reach a value of around USD 2.1 billion in 2024 and is projected to hit nearly USD 5.3 billion by 203... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Targeted Alpha Therapy Market By Isotope Type (Actinium-225, Thorium-227, Bismuth-213, Others); By Therapeutic Area (Prostate Cancer, Leukemia, Glioblastoma, Neuroendocrine Tumors, Others); By End User (Academic Cancer Centers, Oncology Hospitals, Radiopharmacies & Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Alpha Therapy Market is projected to expand at a CAGR of 20.8%, rising from USD 1.34 billion in 2024 to an estimated USD 4.12 billion by 2030, ac... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

CD70 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapy, Bispecific Antibodies); By Indication (Renal Cell Carcinoma, Lymphomas, Acute Myeloid Leukemia, Others); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic & Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD70 Targeting Therapies Market will witness a robust CAGR of 17.4%, valued at USD 1.2 billion in 2024, expected to appreciate and reach ... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Dysmenorrhea Treatment Market By Treatment Type (NSAIDs, Hormonal Therapy, Complementary Therapies, Surgical Intervention); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dysmenorrhea Treatment Market is expected to grow at a CAGR of 6.8% between 2024 and 2030. Valued at USD 6.8 billion in 2024, the market is projected to r... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Fecal Microbiota Transplants (FMT) Market By Product Type (Traditional Fecal Suspensions, Processed Microbiota Formulations); By Route of Administration (Colonoscopy, Enema, Nasogastric/Nasoduodenal Tube, Oral Capsules); By End User (Hospitals, Specialty Clinics, Research Institutes, Stool Banks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Microbiota Transplants (FMT) Market is poised to witness a robust CAGR of approximately 1... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market By Therapy Type (CAR-T Cell Therapy, Bispecific Antibodies, Antibody-Drug Conjugates); By Indication (Multiple Myeloma, Lymphoma, Other B-cell Malignancies); By Line of Therapy (Third-line and Beyond, Earlier-line Settings); By End User (Academic Hospitals, Community Oncology Centers, Specialty Infusion Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market is projected to expand at a... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Autosomal Dominant Polycystic Kidney Disease Market By Drug Class (Vasopressin V2 Receptor Antagonists, Somatostatin Analogs, mTOR Inhibitors, Anti-Inflammatory & Antifibrotic Agents); By Diagnostic & Monitoring Tools (MRI/CT Imaging, Genetic Testing, Biomarker Platforms); By End User (Nephrology Clinics, Specialty Hospitals, Diagnostic/Imaging Centers, Digital Health & Home Monitoring Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Polycystic Kidney Disease (ADPKD) Market will witness a steady CAGR of 5.9%, valued at approximately $2.7 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Autosomal Dominant Optic Atrophy Market By Treatment Type (Gene Therapy, Supportive & Neuroprotective Therapies); By Diagnosis Stage (Early-Stage Diagnosis, Late-Stage Diagnosis); By End User (Academic Hospitals, Ophthalmology Clinics, Genetic Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Optic Atrophy Market is estimated to reach around USD 143 million in 2024 and is projected to grow at a CAGR of 9.6% , ultimately surpassing USD... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Autoimmune Encephalitis Treatment Market By Treatment Type (Acute Immunotherapy, Maintenance Immunotherapy, Adjunctive Care); By Antibody Subtype (Anti-NMDA, LGI1, CASPR2, GABA, AMPA, Others); By End User (Tertiary Hospitals, General Hospitals, Neurology Clinics, Pediatric Centers, Infusion Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Encephalitis Treatment Market is projected to grow at a robust CAGR of 8.1% , with an estimated value of USD 3.2 billion in 2024 and expected to reach U... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Atrophic Vaginitis Treatment Market By Treatment Type (Hormonal [Estrogen Tablets, Creams, Rings, SERMs], Non-Hormonal [Moisturizers, Hyaluronic Acid, Laser & RF Devices]); By Route of Administration (Topical, Oral, Device-Based); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online & Telehealth Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Atrophic Vaginitis Treatment Market is projected to reach $3.1 billion by 2030 , up from $1.9 billion in 2024 , growing at a CAGR of 8.5% over the forecas... Read More

Published Date: DEC-2025 | No Of Pages:181 | $ 4485

Astrocytoma Market By Grade (Low-Grade [Grade I & II], High-Grade [Grade III & IV]); By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy); By End User (Hospitals, Oncology Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Astrocytoma Market will witness a steady CAGR of 5.8%, valued at USD 2.1 billion in 2024, and projected to reach USD 3.0 billion by 2030 , according to Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Aromatase Inhibitors Market By Drug Type (Anastrozole, Letrozole, Exemestane); By Application (Breast Cancer, Ovarian Cancer, Male Breast Cancer, Endometriosis, Fertility Treatment – PCOS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aromatase Inhibitors Market is projected to grow at a CAGR of 5.8% , valued at USD 2.7 billion in 2024 , and expected to reach USD 3.8 billion by ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Angioimmunoblastic T-cell Lymphoma Market By Therapy Type (Chemotherapy Regimens, Targeted Therapies, Monoclonal Antibodies & Biologics, Stem Cell Transplant); By Line of Therapy (First-Line, Second-Line and Beyond); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Angioimmunoblastic T -Cell Lymphoma Market is projected to expand at a CAGR of 8.1% , moving from an es... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Aneurysmal Subarachnoid Hemorrhage Market By Treatment Type (Endovascular Coiling, Surgical Clipping, Pharmacologic Therapy); By Drug Class (Calcium Channel Blockers, Vasodilators, Endothelin Receptor Antagonists, Neuroprotective Agents); By End User (Tertiary Stroke Centers, General Hospitals, Academic Medical Centers, Ambulatory Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysmal Subarachnoid Hemorrhage Market is estimated to be worth USD 1.74 billion in 2024 , and it's projected to reach around Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

ANCA Associated Vasculitis Market By Disease Type (Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis); By Treatment Class (Corticosteroids, Immunosuppressants, Biologic Therapies, Plasma Exchange & Adjunct Therapies); By Route of Administration (Oral, IV, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ANCA Associated Vasculitis (AAV) Market is forecast to expand steadily, with an inferred CAGR of 6.1% , valued at roughly USD 1.6 billion in 2024 and proj... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Alport Syndrome Market By Product Type (Pharmacological Therapies, Gene and Cell Therapies, Supportive Care); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alport Syndrome Market is set to grow at a CAGR of 6.8% , valued at USD 412 million in 2024 , and projected to reach nearly USD 6... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Alpha-1 Antitrypsin Deficiency Market By Therapy Type (Augmentation Therapy, Gene Therapy, Small Molecule Drugs); By Route of Administration (Intravenous, Inhalation, Subcutaneous); By Disease Manifestation (Pulmonary, Liver, Others); By End User (Hospitals, Specialty Clinics, Home Infusion Services, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-1 Antitrypsin Deficiency Market is projected to expand at a steady CAGR of 6.3%, reaching approximately USD 4.1 billion by 2030 , up from an estimated USD 2.... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Alpha Thalassemia Treatment Market By Treatment Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy, HbF Inducers); By Disease Type (Alpha Thalassemia Trait, Hemoglobin H Disease, Hb Bart’s Hydrops Fetalis); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha Thalassemia Treatment Market is projected to expand at a CAGR of 6.9% between 2024 and 2030. The market is valued at approximately USD 536.4 million in 2024 and is e... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Alopecia Areata Market By Treatment Type (Topical Treatments, Oral/Systemic Treatments, Injectable Therapies, Biologics/Pipeline Drugs); By Patient Age Group (Pediatric, Adult); By End User (Hospitals and Specialty Clinics, Outpatient/Community Clinics, Telemedicine/Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alopecia Areata Market will witness a robust CAGR of 7.8 %, valued at an estimated USD 3.2 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Alagille Syndrome Market By Treatment Type (Pharmacological Therapies, Surgical Interventions, Supportive Therapies); By Route of Administration (Oral, Parenteral/Hospital-Based); By End User (Hospitals & Specialty Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alagille Syndrome Market will witness a steady CAGR of 7.5% , valued at around USD 0.46 billion in 2024 and expected to reach nearly Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Age Related Vision Dysfunction Market By Disorder Type (AMD, Cataracts, Glaucoma, Diabetic Retinopathy, Presbyopia); By Treatment Modality (Pharmacological, Surgical, Assistive Technologies, Diagnostic Imaging); By End User (Ophthalmology Clinics, Hospitals & ASCs, Retail Optometry Chains, Home-Based Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Vision Dysfunction Market is projected to grow steadily between 2024 and 2030, with an Compound Annual Growth Rate (CAGR) Of 6.8% . It’s... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Advanced Renal Cell Carcinoma Market By Therapy Class (Tyrosine Kinase Inhibitors, mTOR Inhibitors, Immune Checkpoint Inhibitors, HIF-2α Inhibitors, Bispecifics and Others); By Line of Treatment (First-Line, Second-Line, Later Lines); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Renal Cell Carcinoma Market will witness a CAGR of 7.8% , valued at USD 9.6 billion in 2024 , and projected to reach USD 15.1 billion by 2030 , a... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Adrenoleukodystrophy (ALD) Market By Disease Type (Cerebral ALD, Adrenomyeloneuropathy, Addison-only ALD); By Treatment Modality (Gene Therapy, Stem Cell Transplant, Hormone Replacement, Supportive Therapy, Diagnostics); By End User (Children’s Hospitals, Neurology Clinics, Diagnostic Labs, Endocrinology Centers, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenoleukodystrophy (ALD) Market is gaining attention as diagnostic technologies, gene therapies, and newborn screening programs converge. Valued at USD 505 milli... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Adrenal Crisis Management Market By Product Type (Corticosteroid Injections, Auto-injectors & Prefilled Syringes, Oral Corticosteroids & Adjunct Therapies); By Route of Administration (Intravenous, Intramuscular / Subcutaneous); By End User (Hospitals & Emergency Departments, Ambulatory Clinics, Homecare, EMS Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenal Crisis Management Market is projected to expand steadily, with an inferred CAGR of 6.1% , rising from an estimated USD 3.2 billion in 2024 to arou... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Acute Respiratory Distress Syndrome (ARDS) Treatment Market By Product Type (Mechanical Ventilation Systems, Extracorporeal Membrane Oxygenation, Pharmacologic Therapies, Adjunctive Care Tools); By Route of Administration (Intravenous, Inhalation, Emerging Routes); By End User (Hospitals & Intensive Care Units, Specialty & Academic Centers, General Hospitals, Emergency & Ambulatory Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market will witness a robust CAGR of 6.2% , valued at USD 6.2 billion in 2024 , and ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

Acute Pancreatitis Market By Treatment Type (Supportive Care, Pharmacotherapy, Interventional & Surgical Procedures); By Etiology (Gallstone-Induced, Alcohol-Induced, Hypertriglyceridemia-Induced, Other/Idiopathic); By End User (Hospitals, Specialty Gastroenterology Centers, Ambulatory Surgical Centers, Long-Term Care Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Pancreatitis Market is projected to grow at a steady pace between 2024 and 2030, expanding from an estimated USD 5.8 billion in 2024 to nearly USD 8.6 billio... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Acute on Chronic Liver Failure Market By Treatment Type (Pharmacological Therapy, Liver Support Systems, Organ Transplantation, Plasma Exchange); By End User (Tertiary Care Hospitals, Transplant Centers, Academic Medical Institutions, Specialty Liver Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute on Chronic Liver Failure ( ACLF ) Market is expected to grow at a CAGR of 9.0% , with a total valuation of approxi... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Acute Ocular Pain Market By Treatment Type (Topical NSAIDs, Topical Corticosteroids, Local Anesthetics, Neuropathic Pain Agents, Biologics); By Indication (Post-Operative Eye Pain, Corneal Abrasions & Injuries, Uveitis & Inflammatory Episodes, Chemical Burns, Neuropathic Ocular Pain); By Route of Administration (Topical Drops, Injectables, Oral Medications, Ocular Implants/Inserts); By End User (Ophthalmology Clinics, Hospital Emergency Departments, Ambulatory Surgical Centers, Retail Pharmacies, Teleophthalmology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Ocular Pain Market is projected to grow at a CAGR of 6.4% , estimated at USD 2.1 billion in 2024 and likely to reach around USD 3.1 billion by 2030 ... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Acute Gout Flare Therapeutics Market By Drug Class (NSAIDs, Colchicine, Corticosteroids, Biologic Agents, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Gout Flare Therapeutics Market is projected to advance steadily, reaching an estimated value of USD 4.2 billion in 2024 and expanding to USD 6.1 billion by 2... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Acute Coronary Syndrome Market By Type (STEMI, NSTEMI, Unstable Angina); By Drug Class (Antiplatelet Agents, Anticoagulants, Statins, Beta-Blockers, ACE Inhibitors/ARBs, Thrombolytics); By Device Type (Coronary Stents, Balloon Catheters, IVUS/OCT Imaging, Thrombectomy Devices, Diagnostics); By End User (Hospitals with PCI Facilities, EMS, Secondary Hospitals, Cardiology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Coronary Syndrome Market is set to grow at a robust pace, with a projected CAGR of 6.8% from 2024 to 2030 . Valued at approximately USD 11.2... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market By Drug Class (Oxazolidinones, Lipoglycopeptides, Lipopeptides, Beta-lactams & Cephalosporins, Others); By Route of Administration (Intravenous, Oral, Long-Acting Injectable); By Infection Type (Cellulitis, Wounds, Abscesses, Trauma); By End User (Hospitals, ASCs, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Bacterial Skin and Skin Structure Infections Market is projected to expand steadily, valued at approximately USD 5.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Acid Sphingomyelinase Deficiency (ASMD) Market By Product Type (Enzyme Replacement Therapy, Gene Therapy Candidates, Supportive Care); By Application (Type A – Infantile Neurovisceral, Type B – Chronic Visceral, Type A/B Intermediate); By End User (Specialty & Tertiary Hospitals, Academic & Research Institutes, Home Infusion & Specialty Pharmacies, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acid Sphingomyelinase Deficiency Market will witness a strong growth trajectory, valued at USD 450 million in 2024 and projected to reach approximately Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Achondroplasia Market By Therapy Type (CNP Analogs, FGFR Inhibitors, Adjunctive & Supportive Care); By Patient Age Group (Pediatrics, Adults); By Route of Administration (Subcutaneous Injections, Oral Therapies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondroplasia Market will expand steadily between 2024 and 2030, with the market estimated at USD 1.1 billion in 2024 and projected to reach around USD 2.4 billio... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

LAG-3 Targeting Therapy Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Head & Neck Squamous Cell Carcinoma, Other Solid Tumors, Hematologic Malignancies); By End User (Hospitals, Specialty Cancer Centers, Academic Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global LAG-3 Targeting Therapy Market will witness a strong CAGR of 24.1%, valued at an estimated USD 1.37 billion in 2024 and projected to exce... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

PRMT5 Targeted Therapies Market By Drug Type (Small Molecule Inhibitors, Allosteric Inhibitors, Protein Degraders); By Application (NSCLC, Glioblastoma, Pancreatic Cancer, Mantle Cell Lymphoma, AML, MDS); By Route of Administration (Oral, Intravenous); By End User (Academic Cancer Centers, Oncology Clinics, Community Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PRMT5 Targeted Therapies Market is poised to expand at a robust CAGR of 28.4%, valued at approximately USD 412 million in 2024, and proje... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

CD39 Targeted Therapies Market By Drug Type (Monoclonal Antibodies, Small Molecule Inhibitors); By Therapeutic Application (Oncology, Autoimmune Disorders, Combination Therapy); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD39 Targeted Therapies Market is projected to expand at a CAGR of 16.8%, rising from USD 427.0 million in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Biotherapeutics Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Cell Therapy Products, Gene Therapies, Vaccines); By Application (Oncology, Autoimmune Diseases, Rare Genetic Disorders, Infectious Diseases, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Oral & Others); By End User (Academic & Specialty Hospitals, General Hospitals, Infusion Clinics, Specialty Pharmacies & Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biotherapeutics Market is projected to expand steadily at a CAGR of 8.6%, valued at USD 356.7 billion in 2024, and expec... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Hormonal Contraceptives Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives); By Route of Administration (Oral, Transdermal, Subdermal, Intramuscular, Vaginal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hormonal Contraceptives Market is projected to reach $29.7 billion by 2030, up from an estimated $21.3 billion in 2024, growing at a CAGR of 5.7% during t... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Tumor Infiltrating Lymphocytes (TILs) Market By Therapy Type (Autologous TILs, Genetically Modified TILs); By Indication (Melanoma, NSCLC, Cervical Cancer, Head & Neck Cancer, Others); By Manufacturing Model (Centralized, Decentralized); By End User (Academic Centers, Oncology Hospitals, Cell Therapy Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tumor Infiltrating Lymphocytes (TILs) Market is projected to reach USD 1.26 billion in 2024 and is expected to grow to a... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Venous Thromboembolism (VTE) Treatment Market By Product Type (Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices, Vena Cava Filters); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Venous Thromboembolism (VTE) Treatment Market will witness a steady CAGR of around 6.5%, valued at about USD 10.8 billion in 2024, and ex... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Mitochondrial Disease Therapies Market By Therapy Type (Small Molecules, Gene Therapy, Enzyme Replacement, Others); By Route of Administration (Oral, Injectable/Intravenous, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitochondrial Disease Therapies Market will expand steadily at an CAGR of 9.1%, valued at USD 1.1 billion in 2024, and projected to reach USD 2.0 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Pulmonary Embolism Therapeutics Market By Drug Class (DOACs, LMWH, Unfractionated Heparin, Vitamin K Antagonists, Thrombolytics); By Route of Administration (Oral, Injectable); By Disease Severity (Low-Risk, Submassive, Massive); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Embolism Therapeutics Market is projected to grow at a CAGR of 6.3% , valued at USD 2.7 billion in 2024 and anticipated to reach approximately USD 4.1 bi... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Dimpleplasty Market By Procedure Type (Suturing Technique, Excisional Technique); By Gender (Male, Female); By Age Group (18–25, 26–35, 36–50, 50+); By End User (Cosmetic Surgery Clinics, Aesthetic Dermatology Practices, Hospital-Based Cosmetic Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dimpleplasty Market is projected to grow at a steady CAGR of 9.6% , valued at USD 74.6 million in 2024 and expected to surpass US... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Brachioplasty Market By Technique (Traditional Brachioplasty, Mini Brachioplasty, Extended Brachioplasty, Non-Invasive Techniques); By Gender (Male, Female); By End User (Hospitals, Ambulatory Surgical Centers, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brachioplasty Market will witness a solid CAGR of 8.2% , valued at USD 1.3 billion in 2024 , and projected to reach USD 2.1 billion by 2030 , according to... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Neoantigen Targeted Therapy Market By Therapy Type (Personalized Neoantigen Vaccines, T-cell Based Therapies); By Cancer Indication (Melanoma, NSCLC, Glioblastoma, Bladder Cancer, Colorectal Cancer, Others); By Delivery Platform (mRNA, Peptide, Dendritic Cell, DNA-based); By End User (Academic Medical Centers, Specialty Cancer Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Targeted Therapy Market is projected to expand at a remarkable growth rate, estimated at USD 1.9 billion in 2024 and expected to reach USD 8.5 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Theranostics Market By Therapeutic Area (Oncology, Neurology, Cardiology, Others); By Technology Platform (Radiopharmaceuticals, Nanoparticle Systems, Antibody-Drug Conjugates, RNA-Based Platforms); By End User (Academic & Research Institutions, Specialty Clinics, Tertiary Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Theranostics Market is poised for strong growth between 2024 and 2030, with a projected CAGR of 10.4% , growing from USD 13.6 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Non-Muscle Invasive Bladder Cancer (NMIBC) Market By Therapy Type (Intravesical Therapy, Immuno-Oncology Agents, Surgery & Resection [TURBT], Emerging Therapies); By Route of Administration (Intravesical, Intravenous/Oral); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Muscle Invasive Bladder Cancer (NMIBC) Market will expand steadily at an estimated CAGR of 6.8% , moving from a valuation of USD 2.9 billion in 2024 t... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485